arrow
S

Seung-Tae Lee

korea disease control & prevention agency (kdca)
H指数:39
被引数:7,351

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PROs versus clinician-reported adverse events in a large clinical trial: findings from the Phase 3 POLARIX study

患者报告结果(PROs)与临床医生报告的不良事件在大型临床试验中的比较:来自III期POLARIX研究的结果

Blood
IF23.1
2025-09-290
OA
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

一项关于来那度胺和剂量调整EPOCH-R在MYC相关DLBCL中的多中心Ⅰ/Ⅱ期临床试验

2025-07-290
OAAI
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
2024-06-205
OAAI